MangoRx vs Shed: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent researchHow we rank →

Shed beats MangoRx overall, scoring 7.8/10 vs 7.5/10. Shed is more affordable at $199/mo vs $299/mo. Choose MangoRx for users who want a multi-service telehealth platform covering . Choose Shed for users who want fast delivery and a streamlined compounded gl.

A side-by-side comparison of MangoRx and Shed covering pricing, scores, medication types, insurance, and more to help you decide.

MangoRx

#27 of 48
7.5/10

Multi-service telehealth platform offering compounded GLP-1 alongside other health services.

Visit MangoRx
Higher Rated

Shed

#17 of 48
7.8/10

Newer GLP-1 provider focused on speed and simplicity — fast approvals, fast shipping, and a clean user experience at a competitive price point.

Visit Shed
FeatureMangoRxShed
Our Score7.5/107.8/10
Starting Price$299/mo$199/mo
Medication TypeCompoundedBoth
Insurance AcceptedNoNo
Best ForUsers who want a multi-service telehealth platform covering weight loss and men's healthUsers who want fast delivery and a streamlined compounded GLP-1 experience
Ranking#27#17

Pros & Cons Compared

MangoRx

Pros

  • +Oral dissolving tablets exclusively — zero injections for any GLP-1 option
  • +Publicly traded on NASDAQ (MGRX) — SEC-required financial transparency that private competitors can't match
  • +Semaglutide tablet includes Vitamin B6 to help reduce nausea during treatment
  • +Free 100% online consultation with no video call required

Cons

  • $299/mo for oral semaglutide is 2-3x the cost of injectable alternatives at $99-149/mo
  • Early-stage public company with limited revenue — stock performance reflects financial uncertainty
  • Only oral tablet format available — no injectable options if you want higher bioavailability

Shed

Pros

  • +Industry-leading delivery speed — most patients receive medication within 2-3 days of enrollment
  • +$149/mo is competitively priced for an all-inclusive compounded program with good support
  • +Streamlined onboarding with no video call — approved and shipped faster than most competitors
  • +Clean, modern UX with real-time shipping tracking and easy provider messaging

Cons

  • Compounded semaglutide and tirzepatide only — no brand-name options
  • Newer company (founded 2024) with limited track record and outcome data
  • No insurance billing and no FSA/HSA superbills currently available
  • Clinical support is responsive but less proactive than premium platforms

Our Verdict

Shed edges out MangoRx with a score of 7.8/10 vs 7.5/10. If budget is your priority, Shed starts at $199/mo compared to MangoRx's $299/mo. Shed offers both brand-name and compounded medications, giving you more flexibility. Choose MangoRx if you want: users who want a multi-service telehealth platform covering weight loss and men's health. Choose Shed if you want: users who want fast delivery and a streamlined compounded glp-1 experience.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither MangoRx nor Shed feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Try MangoRx

Starting at $299/mo

Visit MangoRx

Try Shed

Starting at $199/mo

Visit Shed

Related comparisons

Other matchups readers comparing MangoRx or Shed tend to look at next.

Top Picks

Four programs our readers click through most.

Embody

7.3/10
$299/mo·Compounded

Gala

7.2/10
$149/mo·Brand & Compounded

Sesame Care

7.9/10
$99/mo·Brand & Compounded

Affiliate links — we earn a commission at no extra cost to you. Selection reflects what readers convert through, not editorial endorsement. Full ranking + methodology at glp1picks.com.